>>>Borderline products: Cranberry products cannot be regarded as medical devices (Loyens & Loeff)

Borderline products: Cranberry products cannot be regarded as medical devices (Loyens & Loeff)

The European Commission’s Regulatory Committee on Medical Devices has adopted a Commission Decision on the qualification of cranberry products. According to the Decision, cranberry products do not fall within the definition of medical devices set out in the Medical Devices Directive.

The European Commission’s Regulatory Committee on Medical Devices has adopted a Commission Implementing Decision on the qualification of cranberry products. The Decision states that products “whose principal intended action, depending on proanthocyanidins present in cranberry (Vaccinium Macrocarpon) extract, is to prevent or treat cystitis”, are not medical devices within the meaning of Article 1 (2) (a) of the Medical Devices Directive.

Read the full article here

2017-06-06T16:13:16+00:00 6 juni 2017|Categories: Pharma & lifesciences|Tags: , , |